Huiyu Pharmaceutical

Sichuan Huiyu Pharmaceutical Co., Ltd. is a research and development-driven pharmaceutical enterprise established in 2010. The company primarily focuses on the R&D, production, and sale of anti-tumor and injectable drugs. Its product portfolio includes generic and innovative drugs for oncology, anti-infectives, and other therapeutic areas, with key products like Pemetrexed Disodium, Irinotecan Hydrochloride, and Docetaxel.

The company was founded by Dr. Zhao Ding, who returned to China with the mission of improving access to cancer treatments and transforming cancer into a controllable chronic disease. Based in Neijiang, Sichuan, the company has expanded its global footprint with subsidiaries in the United Kingdom, the United States, and Ireland. Huiyu Pharmaceutical operates through a business model that includes the sale of high-quality generic drugs, the development of innovative new drugs, and providing contract development and manufacturing organization (CDMO) services. Its customer base includes hospitals, healthcare institutions, wholesale distributors, and retail pharmacies, which it reaches through direct sales and partnerships.

Huiyu Pharmaceutical's manufacturing facilities are compliant with global regulatory standards and have received approvals from authorities such as the China NMPA, US FDA, and European Medicines Agency (EMA). The company is engaged in developing a pipeline of innovative drugs, including antibody-drug conjugates (ADCs) and small molecule drugs for treating advanced solid tumors. It has also strategically invested in other biotech firms to enrich its innovative drug pipeline.

Keywords: oncology drugs, injectable pharmaceuticals, generic drugs, active pharmaceutical ingredients, API manufacturing, cancer treatment, CDMO services, drug development, antibody-drug conjugates, small molecule drugs, anti-infective, pharmaceutical manufacturing, clinical trials, Pemetrexed, Irinotecan, Docetaxel, EU GMP, FDA approved, research and development, pharmaceutical innovation